£105.77

It has never been this cheap. We have no record of a lower price.

£106 today · cheaper than every other day in the last 3 months

Birkhauser Glutamate-based Therapies for Psychiatric Disorders (Milestones in Drug Therapy)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days · 35 data points (no recent data)

Historical
Generating forecast…
£108.01 £105.55 £106.08 £106.62 £107.16 £107.70 £108.23 12 August 2026 20 August 2026 29 August 2026 06 September 2026 15 September 2026
View at Amazon ↗

Price data last checked 56 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 35 days • 2 price levels

Days at Price
Current Price
19 days · current 16 days 0 5 10 14 19 £106 £108 Days at Price

Price Analysis

Most common price: £106 (19 days, 54.3%)

Price range: £106 - £108

Price levels: 2 different prices over 35 days

Description

Both metabotropic and ionotropic glutamate receptors present attractive “druggable” targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This “Milestones in Drug Therapy” volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Synaptic Stress and Pathogenesis of Neuropsychiatric Disorders
84% match

Synaptic Stress and Pathogenesis of Neuropsychiatric Disorders

Springer

£104.74 13 Sep 2026
The Glutamate Receptors (The Receptors)
83% match

The Glutamate Receptors (The Receptors)

Humana

£141.86 31 Aug 2026
Synaptic Stress and Pathogenesis of Neuropsychiatric Disorders
83% match

Synaptic Stress and Pathogenesis of Neuropsychiatric Disorders

Springer

£114.71 22 Oct 2026
Textbook of Neuroscience for Psychiatrists: From Neural Circuits to Clinical Practice
82% match

Textbook of Neuroscience for Psychiatrists: From Neural Circuits to Clinical Practice

£66.29 04 Nov 2026
Brain Protection in Schizophrenia, Mood and Cognitive Disorders
82% match

Brain Protection in Schizophrenia, Mood and Cognitive Disorders

Springer

£148.47 03 Nov 2026
82% match

Neurosteroids: Therapeutics and Biomarkers (Frontiers in Neuroscience)

CRC Press

£100.00 25 Aug 2026
The Ionotropic Glutamate Receptors (The Receptors)
82% match

The Ionotropic Glutamate Receptors (The Receptors)

Humana

£111.37 23 Oct 2026
Neurological and Psychiatric Disorders (Current Clinical Neurology)
82% match

Neurological and Psychiatric Disorders (Current Clinical Neurology)

Humana

£103.27 24 Oct 2026
Neurotherapeutics: Emerging Strategies (Contemporary Neuroscience)
82% match

Neurotherapeutics: Emerging Strategies (Contemporary Neuroscience)

Humana

£83.20 15 Sep 2026
Maintenance Pharmacotherapies for Neuropsychiatric Disorders
82% match

Maintenance Pharmacotherapies for Neuropsychiatric Disorders

Routledge

£51.08 20 Oct 2026
Deep Brain Stimulation in Neurological and Psychiatric Disorders (Current Clinical Neurology)
81% match

Deep Brain Stimulation in Neurological and Psychiatric Disorders (Current Clinical Neurology)

Humana

£170.00 15 Sep 2026
Psychiatric Disorders: Methods and Protocols: 829 (Methods in Molecular Biology, 829)
81% match

Psychiatric Disorders: Methods and Protocols: 829 (Methods in Molecular Biology, 829)

Humana

£103.09 15 Sep 2026
Behavioral Neurobiology of Schizophrenia and Its Treatment: 4 (Current Topics in Behavioral Neurosciences, 4)
81% match

Behavioral Neurobiology of Schizophrenia and Its Treatment: 4 (Current Topics in Behavioral Neurosciences, 4)

Springer

£148.21 24 Oct 2026
Non Invasive Brain Stimulation in Psychiatry and Clinical Neurosciences
81% match

Non Invasive Brain Stimulation in Psychiatry and Clinical Neurosciences

Springer

£86.87 27 Oct 2026
Growth Factors and Psychiatric Disorders: 289 (Novartis Foundation Symposia)
81% match

Growth Factors and Psychiatric Disorders: 289 (Novartis Foundation Symposia)

Wiley

£160.95 16 Sep 2026
Ketamine: From Abused Drug to Rapid-Acting Antidepressant
81% match

Ketamine: From Abused Drug to Rapid-Acting Antidepressant

Springer

£113.98 16 Sep 2026
Animal Models of Schizophrenia and Related Disorders: 59 (Neuromethods, 59)
81% match

Animal Models of Schizophrenia and Related Disorders: 59 (Neuromethods, 59)

Humana

£95.74 24 Oct 2026
Current Psychotherapeutic Drugs
81% match

Current Psychotherapeutic Drugs

Routledge

£54.99 16 Sep 2026
The Medical Basis of Psychiatry
81% match

The Medical Basis of Psychiatry

Humana

£148.19 23 Oct 2026
Biology of Schizophrenia and Affective Disease
81% match

Biology of Schizophrenia and Affective Disease

American Psychiatric Association Publishing

Price unavailable
The NMDA Receptors: 30 (The Receptors, 30)
81% match

The NMDA Receptors: 30 (The Receptors, 30)

Humana

£108.42 22 Oct 2026
Therapeutic rTMS in Neurology: Principles, Evidence, and Practice Recommendations
80% match

Therapeutic rTMS in Neurology: Principles, Evidence, and Practice Recommendations

Springer

£95.74 20 Oct 2026
Psychopharmaka bei psychiatrischen Erkrankungen: Neuroleptika, Tranquilizer, Antidepressiva. Anwendungsgrundsätze, Nebenwirkungen, Kontraindikationen, spezielle Hinweise und tabellarische Übersicht
80% match

Psychopharmaka bei psychiatrischen Erkrankungen: Neuroleptika, Tranquilizer, Antidepressiva. Anwendungsgrundsätze, Nebenwirkungen, Kontraindikationen, spezielle Hinweise und tabellarische Übersicht

Vieweg+Teubner Verlag

£57.09 23 Oct 2026
Physiologie des maladies mentales: Anomalies neurobiologiques et conséquences thérapeutiques en psychiatrie
80% match

Physiologie des maladies mentales: Anomalies neurobiologiques et conséquences thérapeutiques en psychiatrie

Elsevier Masson

£39.67 03 Nov 2026